Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1140
-0.0010 (-0.87%)
Aug 13, 2026, 1:56 PM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 76.08 million as of August 13, 2026. Its market cap has decreased by -24.66% in one year.
Market Cap
76.08M
Enterprise Value
50.16M
Revenue
4.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
ChartMarket Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 76.08M, an increase of 63.82%. That is a compound annual growth rate of 3.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 75.42M | -2.15% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 143.93M |
| NextCell Pharma AB | 134.48M |
| Annexin Pharmaceuticals AB | 89.30M |
| OncoZenge AB | 80.78M |
| Ascelia Pharma AB | 76.12M |
| AcouSort AB | 73.02M |
| Disruptive Pharma AB | 61.80M |
| Pila Pharma AB | 60.99M |